Antipsychotic dose and diminished neural modulation: A multi-site fMRI study

BACKGROUND The effect of antipsychotics on the blood oxygen level dependent signal in schizophrenia is poorly understood. The purpose of the present investigation is to examine the effect of antipsychotic medication on independent neural networks during a motor task in a large, multi-site functional magnetic resonance imaging investigation. METHODS Seventy-nine medicated patients with schizophrenia and 114 comparison subjects from the Mind Clinical Imaging Consortium database completed a paced, auditory motor task during functional magnetic resonance imaging (fMRI). Independent component analysis identified temporally cohesive but spatially distributed neural networks. The independent component analysis time course was regressed with a model time course of the experimental design. The resulting beta weights were evaluated for group comparisons and correlations with chlorpromazine equivalents. RESULTS Group differences between patients and comparison subjects were evident in the cortical and subcortical motor networks, default mode networks, and attentional networks. The chlorpromazine equivalents correlated with the unimotor/bitemporal (rho=-0.32, P=0.0039), motor/caudate (rho=-0.22, P=0.046), posterior default mode (rho=0.26, P=0.020), and anterior default mode networks (rho=0.24, P=0.03). Patients on typical antipsychotics also had less positive modulation of the motor/caudate network relative to patients on atypical antipsychotics (t(77)=2.01, P=0.048). CONCLUSION The results suggest that antipsychotic dose diminishes neural activation in motor (cortical and subcortical) and default mode networks in patients with schizophrenia. The higher potency, typical antipsychotics also diminish positive modulation in subcortical motor networks. Antipsychotics may be a potential confound limiting interpretation of fMRI studies on the disease process in medicated patients with schizophrenia.

[1]  P. Liddle,et al.  Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia. , 2004, Journal of psychiatry & neuroscience : JPN.

[2]  Gabriele Ende,et al.  Cortical response to motor stimulation in neuroleptic-naive first episode schizophrenics , 2000, Psychiatry Research: Neuroimaging.

[3]  Jonathan D. Cohen,et al.  Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. , 2005, The American journal of psychiatry.

[4]  L R Schad,et al.  Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication. , 1994, Magnetic resonance imaging.

[5]  Carol A. Tamminga,et al.  Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.

[6]  P. Liddle,et al.  Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus , 2000, British Journal of Psychiatry.

[7]  Gabriele Ende,et al.  Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients , 1999, Schizophrenia Research.

[8]  E. Richelson,et al.  Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. , 1984, European journal of pharmacology.

[9]  J. Callicott,et al.  Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine , 2004, Biological Psychiatry.

[10]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[11]  Vince D. Calhoun,et al.  A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data , 2009, NeuroImage.

[12]  V. Calhoun,et al.  Aberrant "default mode" functional connectivity in schizophrenia. , 2007, The American journal of psychiatry.

[13]  L. Schad,et al.  Sensorimotor Cortex and Supplementary Motor Area Changes in Schizophrenia , 1995, British Journal of Psychiatry.

[14]  S. Rombouts,et al.  Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.

[15]  Tülay Adali,et al.  Estimating the number of independent components for functional magnetic resonance imaging data , 2007, Human brain mapping.

[16]  M. Buchsbaum,et al.  FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia , 2008, Schizophrenia Research.

[17]  Deborah A. Yurgelun-Todd,et al.  Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation , 2004, Psychiatry Research: Neuroimaging.

[18]  G. Juckel,et al.  Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation , 2010, Schizophrenia Research.

[19]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[20]  Jean-Francois Mangin,et al.  What is the best similarity measure for motion correction in fMRI time series? , 2002, IEEE Transactions on Medical Imaging.

[21]  J. Lieberman,et al.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.

[22]  Niels G. Waller The Scale for the Assessment of Negative Symptoms , 1995 .

[23]  M. Egan,et al.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. , 2003, The American journal of psychiatry.

[24]  Vincent J Schmithorst,et al.  Comparison of three methods for generating group statistical inferences from independent component analysis of functional magnetic resonance imaging data , 2004, Journal of magnetic resonance imaging : JMRI.

[25]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[26]  Randy L. Gollub,et al.  Multi-site characterization of an fMRI working memory paradigm: Reliability of activation indices , 2010, NeuroImage.

[27]  P. Liddle,et al.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change , 2002, Journal of neurology, neurosurgery, and psychiatry.

[28]  G. Schuierer,et al.  Subcortical overactivation in untreated schizophrenic patients: A functional magnetic resonance image finger‐tapping study , 2002, Psychiatry and clinical neurosciences.

[29]  Wei Deng,et al.  Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging. , 2010, Archives of general psychiatry.

[30]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[31]  P. Riederer,et al.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder , 2006, Neurotoxicity Research.

[32]  R E Litman,et al.  The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. , 1997, Archives of general psychiatry.

[33]  H. Holcomb,et al.  Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex , 2004, Neuropsychopharmacology.

[34]  J. Kane,et al.  The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. , 2003, The Journal of clinical psychiatry.

[35]  T. Barnes A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.

[36]  N. Nair,et al.  The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic Patients , 1987, Journal of clinical pharmacology.

[37]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[38]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[39]  E. Bullmore,et al.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Chollet,et al.  Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. , 2000, Brain : a journal of neurology.

[41]  R. Coppola,et al.  Functional Magnetic Resonance Imaging Brain Mapping in Psychiatry: Methodological Issues Illustrated in a Study of Working Memory in Schizophrenia , 1998, Neuropsychopharmacology.

[42]  W. Wirshing Movement disorders associated with neuroleptic treatment. , 2001, The Journal of clinical psychiatry.

[43]  Jürgen Winkler,et al.  Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study. , 2003, Psychiatry and clinical neurosciences.

[44]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  V. Calhoun,et al.  Functional neural circuits for mental timekeeping , 2007, Human brain mapping.

[46]  Vince D. Calhoun,et al.  Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls , 2009, NeuroImage.

[47]  Stephen M. Smith,et al.  Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[48]  J. Pekar,et al.  A method for making group inferences from functional MRI data using independent component analysis , 2001, Human brain mapping.

[49]  L. Freire,et al.  Motion Correction Algorithms May Create Spurious Brain Activations in the Absence of Subject Motion , 2001, NeuroImage.

[50]  Lothar R. Schad,et al.  Motor Dysfunction and Sensorimotor Cortex Activation Changes in Schizophrenia: A Study with Functional Magnetic Resonance Imaging , 1999, NeuroImage.

[51]  E. Richelson Receptor pharmacology of neuroleptics: relation to clinical effects. , 1999, The Journal of clinical psychiatry.

[52]  Robert S. Astur,et al.  An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients , 2008, Schizophrenia Research.

[53]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[54]  Terrence J. Sejnowski,et al.  An Information-Maximization Approach to Blind Separation and Blind Deconvolution , 1995, Neural Computation.

[55]  S. Kapur,et al.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.

[56]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[57]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[58]  Carol A Tamminga,et al.  Functional effects of antipsychotic drugs: comparing clozapine with haloperidol , 2003, Biological Psychiatry.

[59]  M. Morrell,et al.  The Expert Consensus Guideline Series Treatment of Epilepsy , 2001, Epilepsy & Behavior.

[60]  J. Kane,et al.  Optimizing pharmacologic treatment of psychotic disorders , 2003 .

[61]  Andreas Meyer-Lindenberg,et al.  D2 Antidopaminergic Modulation of Frontal Lobe Function in Healthy Human Subjects , 2006, Biological Psychiatry.